In a recent study published in the International Journal of Obesity, researchers assessed the effectiveness of semaglutide dosages between 0.25 and 2.4 mg in overweight or obese people for up to one ...

When it comes to semaglutide, withdrawal symptoms can involve changes related to weight, appetite, blood sugar levels, and cardiovascular health. When you regularly take a medication that alters ...

Semaglutide treats type 2 diabetes and can support weight loss with diet and exercise. It works by mimicking glucagon-like peptide-1 (GLP-1) to boost insulin and reduce appetite. Compounded ...

A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug in adolescents has been lacking. In ...

Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a ...

GLP-1s, or glucagon-like peptide-1 medications, have shown promise at treating obesity, a condition that affects a large swath of Americans and contributes to worse health outcomes. But the drugs are ...

Obesity and type 2 diabetes are prevalent in patients with heart failure with preserved ejection fraction and are characterized by a high symptom burden. No approved therapies specifically target ...

While compounded semaglutide is still available, accessing it will be more difficult now that the FDA has declared the semaglutide shortage over. But it should be easier to access approved, ...